Search
01/01/2022
SER-SEPAR recommendations for the the management of rheumatoid arthritis-related interstitial lung disease. Part 2: Treatment
Narváez J., Díaz del Campo Fontecha P., Brito García N., Bonilla G., Aburto M., Castellví I., Cano-Jiménez E., Mena-Vázquez N., Nieto M.A., Ortiz A.M., Valenzuela C., Abad Hernández M.Á., Castrejón I., Correyero Plaza M., Francisco Hernández F.M., Hernández Hernández M.V., Rodríquez Portal J.A.. SER-SEPAR recommendations for the the management of rheumatoid arthritis-related interstitial lung disease. Part 2: Treatment. Reumatologia Clinica. 2022; 18(9)DOI:10.1016/j.reuma.2022.03.005. PMID:36064885. IF:(Q/D).
01/01/2022
SER-SEPAR recommendations for the management of rheumatoid arthritis-related interstitial lung disease. Part 1: Epidemiology, risk factors and prognosis
Rodríguez Portal J.A., Brito García N., Díaz del Campo Fontecha P., Valenzuela C., Ortiz A.M., Nieto M.A., Mena-Vázquez N., Cano-Jiménez E., Castellví I., Aburto M., Bonilla G., Hernández Hernández M.V., Hernández F.M.F., Correyero Plaza M., Castrejón I., Abad Hernández M.Á., Narváez J.. SER-SEPAR recommendations for the management of rheumatoid arthritis-related interstitial lung disease. Part 1: Epidemiology, risk factors and prognosis. Reumatologia Clinica. 2022; 18(8)DOI:10.1016/j.reuma.2022.02.009. PMID:36085196. IF:(Q/D).
01/01/2022
Correction to: Real-world Treatment Patterns and Clinical Outcomes of Baricitinib in Rheumatoid Arthritis patients in Spain: Results of a multicenter, observational study in routine clinical practice (The ORBIT-RA Study) (Rheumatology and Therapy, (2022), 9, 2, (589-608), 10.1007/s40744-021-00423-8)
Hernández-Cruz B., Rosas J., Díaz-Torné C., Belzunegui J., García-Vicuña R., Inciarte-Mundo J., Pons A., Millán A.M., Jeria-Navarro S., Valero J.A., García-Castañeda N., Valero C., Llorente I., Calvo A., Díaz-Cerezo S., Núñez M.. Correction to: Real-world Treatment Patterns and Clinical Outcomes of Baricitinib in Rheumatoid Arthritis patients in Spain: Results of a multicenter, observational study in routine clinical practice (The ORBIT-RA Study) (Rheumatology and Therapy, (2022), 9, 2, (589-608), 10.1007/s40744-021-00423-8). Rheumatology and Therapy. 2022; 9(4)DOI:10.1007/s40744-022-00463-8. PMID:35653064. IF:3.800(Q3/6D).
01/01/2022
Myo-Spain: Spanish Registry of Patients with Idiopathic Inflammatory Myopathy. Methodology
Cobo-Ibáñez T., Sánchez-Piedra C., Nuño-Nuño L., Castellví I., Carrión-Barberà I., Romero-Bueno F., Narváez J., Trallero-Araguás E., Tomero E., Ruiz-Lucea M.E., Larena C., Carrasco Cubero C., Jovaní V., Barbadillo C., Sivera F., Belzunegui J., Pérez Gómez A., Gómez Gómez A., Delgado-Frías E., Pego-Reigosa J.M., Joven B., Ibáñez M., Martínez-González O., Ruiz-Román A., Camins J., Ortega-Castro R., Trenor Larra P., Rodríguez López M., Freire M., Alcocer P., Holgado S., Rúa-Figueroa I., Lozano N., Martínez-Barrio J.. Myo-Spain: Spanish Registry of Patients with Idiopathic Inflammatory Myopathy. Methodology. Reumatologia Clinica. 2022; 18(5)DOI:10.1016/j.reuma.2021.01.007. PMID:33867271. IF:(Q/D).
01/01/2022
Severe Disease in Patients With Recent-Onset Psoriatic Arthritis. Prediction Model Based on Machine Learning
Queiro R., Seoane-Mato D., Laiz A., Galindez Agirregoikoa E., Montilla C., Park H.S., Pinto Tasende J.A., Bethencourt Baute J.J., Joven Ibáñez B., Toniolo E., Ramírez J., Pruenza García-Hinojosa C.. Severe Disease in Patients With Recent-Onset Psoriatic Arthritis. Prediction Model Based on Machine Learning. Frontiers in Medicine. 2022; 9DOI:10.3389/fmed.2022.891863. PMID:35572968. IF:3.900(Q2/4D).
01/01/2022
Recomendaciones para el diagnóstico y tratamiento de la baja masa ósea para la edad cronológica y la osteoporosis infantil en Atención Primaria
Mir-Perelló C., López B.M., Pérez B.S., Torrent R.B., Fernández M.I.G., Corbeto M.L., Gil J.G., Zavala R.G.. Recomendaciones para el diagnóstico y tratamiento de la baja masa ósea para la edad cronológica y la osteoporosis infantil en Atención Primaria. Pediatria De Atencion Primaria. 2022; 24(94)DOI:. PMID:. IF:(Q/D).